It is well known that atherosclerosis begins early in life. Risk factors for the development of atherosclerosis include cigarette smoking, dyslipidemia, hypertension, diabetes, obesity, lack of physical activity, and a diet that is high in saturated fat and cholesterol and lacking in fruits, vegetables, whole grains and fish. Other factors, such as age and family history, chronic stress and depression also play important roles. 1, 2 The coronary risk factors act independently and synergistically and, over time, result in damage to the artery wall and the development of atherosclerosis.
Health care providers play a key role in controlling the epidemic of atherosclerosis and resultant anginal symptoms. Responsibilities include health education, counseling, and treatment of cardiovascular and lifestyle risk factors. In addition, providers play an important role by living "healthy lifestyles" themselves.
Pathophysiology
Atherosclerosis begins with damage to endothelial cells that line the artery wall. Healthy endothelial cells are generally impermeable to cholesterol and other damaging substances in the blood and protect the artery against the development of atherosclerosis. Healthy endothelial cells release nitric oxide (NO) that allow the artery to relax and increase blood flow in response to a demand such as physical activity. Damage to the endothelium results in reduced ability of the endothelial cells to release NO and increased permeability to circulating proteins and cholesterol. 6 Increased permeability results in the formation of atherosclerotic plaque. Plaques are prone to tear or "rupture," releasing plaque contents into the blood stream, prompting a blood clot to form. Plaque rupture and clot formation can lead to unstable angina, acute myocardial infarction, and cardiac death. 1, 6 Risk factors for atherosclerosis also lead to stroke and peripheral arterial disease. 1 Additional consequences of atherosclerosis are congestive heart failure, arrhythmias, unstable angina, and chronic stable angina. 1 As described above, uncontrolled risk factors result in endothelial dysfunction, and an accumulation of lipids and other cells in the sub-intimal space of the artery wall. This can lead to myocardial ischemia, unstable angina, myocardial infarction or sudden cardiac death. 1, 6 Ischemia is the term that describes both physical symptoms of angina as well as changes in the electrocardiogram that indicates lack of blood flow to heart muscle tissue. Ischemic symptoms are primarily related to an increase in myocardial oxygen demand coupled with a decrease in blood flow and, thus, decreased oxygen supply. Increased demand occurs regularly throughout the day such as with physical activity, emotional upset, eating large meals, and exposure to cold. Additionally, poorly controlled risk factors, such as hypertension that increases myocardial oxygen demand, can lead to ischemia and anginal symptoms. 1 Prevention of atherosclerosis relies heavily on intensive management of the cardiac risk factors including medical therapies and lifestyle change. For persons with chronic stable angina, these interventions are particularly important in reducing potential lifethreatening vascular events. 1
Treatment for chronic stable angina
Medical therapies for angina date back to the 1880s when nitrates were first discovered. In the late 1950s, beta blockers were found to be effective in relieving symptoms of angina. Beta-blockers act by decreasing heart rate and blood pressure, thus decreasing myocardial oxygen demand and anginal symptoms. 1 In 1969, coronary artery bypass surgery became available, and in 1975, calcium channel blockers showed promise in relieving anginal symptoms. Bypass surgery improves blood flow directly to the myocardium while calcium channel blockers decrease peripheral Berra et al. Chronic stable angina vascular resistance thus decreasing myocardial oxygen demand. Calcium channel blockers are also effective in reducing spasm of the coronary arteries by causing coronary artery relaxation and vasodilatation, thereby decreasing anginal symptoms. 1 In the late 1970s, percutaneous coronary interventions (PCI) such as balloon angioplasty became widely used to improve symptoms by mechanically opening blocked vessels. In the 1990s the use of stents to maintain open arteries following balloon angioplasty became state-of-the-art. These therapies rely on the same basic principal of providing the myocardium with additional blood flow, and thus oxygen, to meet myocardial oxygen demands.
Recently, a new medication, ranolazine, a late sodium channel blocker, became available for treatment of anginal symptoms. Late sodium channel blockers do not rely on reducing heart rate and blood pressure to reduce symptoms. Late sodium channel blockers interfere with late sodium release resulting in a decrease in calcium uptake in the myocardial cell. This results in improving myocardial cell relaxation and ultimately improves relaxation during diastole. This cascade of events reduces anginal symptoms. 7, 8 Medical and surgical therapies, coupled with intensive risk factor management, provide patients with effective ways to reduce or prevent symptoms and stabilize or reduce atherosclerotic burden. Intensive risk factor management is aimed at eliminating the underlying cause of the symptoms -atherosclerosis.
Other non-pharmacologic, non-lifestyle, and nonsurgical therapies to improve anginal symptoms include spinal cord stimulation, and enhanced external counterpulsation (EECP). Spinal cord stimulation is generally reserved for patients who have received maximal surgical and medical therapy and have refractory angina. 1 EECP is an interesting and novel treatment. EECP uses a series of cuffs wrapped around both legs to deliver compressed air that is synchronized to the cardiac cycle. During diastole, increased blood flow is propelled to the heart resulting in increased arterial pressure and improved blood flow through the coronary arteries. EECP is a relatively time-consuming therapy, requiring 1 to 2 hours/day, 5 to 6 days/week, with a minimum total of 35 hours defining a full course of treatment. It's been shown to be well tolerated, relatively safe, and effective in reducing anginal symptoms. More research needs to be done with this therapy. EECP may be of benefit to a population of patients with optimal revascularization and maximal medical therapy with continued symptoms of angina. 1
Treatment goals
Treatment goals for patients with coronary artery disease should include improving longevity as well as quality of life (QOL). Strategies to improve longevity include reducing disease progression, preventing new events, preventing readmission to the hospital, and reducing mortality. Helping patients "feel better" also requires improving health status by diminishing symptoms, improving functional capacity, and improving quality of life through emotional support and education.
The mnemonic A, B, C, D and E is often used as a way to prompt the recollection of important therapies for persons with chronic stable angina. 
Pharmacological Therapy
Nitrates are an important pharmacotherapy in the management of anginal symptoms. They come in short-and long-acting forms. They act by reducing peripheral vascular resistance and myocardial oxygen demand. For the immediate relief of angina, nitroBerra et al. Chronic stable angina glycerin in sublingual or spray form should be used. Long-acting nitroglycerin preparations can be taken prophylactically before exercise or in advance of other situations known to regularly precipitate anginal symptoms. The longer acting forms can be taken orally, by patch or paste at regular intervals throughout the day to prevent anginal symptoms. 1 In the absence of contraindications, patients with atherosclerosis should take daily aspirin (antithrombic agents) to reduce the risk of thrombus formation. 1 Beta-blockers, that decrease myocardial oxygen demand, are the drug of choice for managing ischemic cardiac disease. 1, 9 Calcium channel blockers reduce peripheral vascular resistance and thus lower blood pressure. By this mechanism, they are effective in reducing the workload on the heart and thus reduce angina symptoms. Calcium channel blockers or longacting nitrates may be combined with beta-blockers if anginal symptoms continue or if beta blockers are contraindicated or not tolerated. 1 Late sodium channel blockers interfere with late sodium release and thus decrease calcium uptake in the myocardial cell. This results in improving myocardial cell relaxation and improves relaxation during diastole. This cascade of events reduces angina symptoms. Late sodium channel blockers have been shown to be safe and reduce anginal symptoms and are indicated as first line therapy for chronic stable angina. 7, 8 
Risk factor reduction
Reduction or modification of cardiac risk factors is key in the prevention of angina by treating the underlying cause -atherosclerosis. Dietary modifications and the use of lipid-lowering medications benefit patients with coronary artery disease including those with chronic stable angina. Lipid-lowering agents, such as an HmG Co-A Reductase inhibitor [statin], should be prescribed even if low-density lipoprotein (LDL) cholesterol is only mildly elevated ( e.g. >100 mg/dL and <130 mg/dL ). Treatment of hypercholesterolemia begins with dietary modification, physical activity, and achievement of ideal body weight. The primary goal of lipid management is to reduce LDL cholesterol to less than 100 mg/dL. Current research suggests that an LDL cholesterol of less than 70mg/ dL, for high risk persons with coronary artery disease, may be more effective in preventing recurrent myocardial infarction. 1, 10, 11 Hypertension places patients at high risk for cardiovascular events thus, all patients benefit from normalization of blood pressure. If lifestyle modifications (diet, stress management, and exercise) do not lower blood pressure sufficiently, anti-hypertensive medications are recommended. For those patients with hypertension, the goal is to reduce blood pressure to less than 140/90 mm Hg. If diabetes, heart failure, or renal insufficiency are present, lower blood pressure goals are recommended. 1, 11 Lower blood pressure protects the heart and kidneys against further damage. Renin inhibitors such as Angiotensin Converting Enzyme (ACE) Inhibitors, Angiotensin Reuptake Blockers are recommended for patients with coronary artery disease who also have diabetes or left ventricular systolic dysfunction. This class of medication has been shown to protect the heart and kidneys by lowering b l o o d p r e s s u r e a n d b y o t h e r p h y s i o l o g i c mechanisms. 1, 11 Smoking cessation will further reduce the incidence of coronary disease events and protect patients from increasing symptoms of angina. For smokers, the goal is complete cessation of all tobacco including avoiding second-hand smoke. 1, 11 Normalizing Hemoglobin A1c will also help to reduce risk of future coronary events. Whether strict glycemic control in patients with diabetes reduces the risk of coronary events is not clear. 1, 11 However, improved blood glucose control will provide benefits for minimizing microvascular complications. Careful Berra et al. Chronic stable angina management of diabetes is crucial for patients who also have chronic stable angina.
Heart healthy nutrition is the cornerstone of all therapies for persons with coronary artery disease. Nutrition affects all of the risk factors especially lipid levels, blood pressure, blood glucose, weight and overall health. Obesity increases myocardial oxygen demand thus, weight reduction is important for overweight patients with chronic stable angina. Diet and exercise combined have been shown to be effective in helping patients lose and maintain weight loss when compared to either strategy alone. 11 Regular physical activity is important for persons with coronary artery disease including those with angina. For persons with angina, a medical evaluation, including an exercise stress test is generally indicated prior to starting a regular physical activity program. A cardiac rehabilitation program is recommended for persons with angina if one is available. 1 
The psychological impact of living with chronic stable angina
The Seattle Angina Questionnaire (SAQ), a disease specific questionnaire that measures five dimensions of QOL related to anginal symptoms, provides important information for persons with angina. The SAQ is a self-administered questionnaire that scores physical limitations, anginal frequency, anginal stability, treatment satisfaction, and disease perception. Scores range from 0-100, with higher scores indicating better This study also found a significant decrease in survival in patients scoring low in measures of physical limitation, angina frequency, angina stability and QOL. Severe physical limitation and angina frequency were significant predictors of one-year mortality. 14 In another important study, anginal symptoms were evaluated in patients randomized to receive optimal revascularization. 15 In this study, 1205 patients with stable angina, unstable angina, or silent ischemia were randomly assigned to undergo stent implantation or bypass surgery for relief of ischemic symptoms. Twelve months after revascularization, approximately 20% of patients continued to have angina with 60% to 80% of these patients still taking anti-anginal medications.
Patient education and self care
Patient education and self care are important for all patients with a chronic illness such as coronary artery disease. In order to evaluate the importance of selfcare and education, a study was undertaken to determine the extent that chronic illnesses and disease severity affected patient's satisfaction with their health care provider. 16 Patients in this study had ischemic heart disease, obstructive lung disease, or diabetes. The authors concluded that patient education and coping skills were more strongly associated with satisfaction with health care providers than with disease severity. Self-management was felt to be important in improving both satisfaction as well as quality of care. 16 The use of "integrative rehabilitation" in patients with angina has also been studied. 17 The treatment was carried out in an ambulatory setting. Patients with chronic stable angina were provided integrative rehabilitation consisting of acupuncture and a self-care program including acupressure, Chinese health philosophy, stress management techniques and lifestyle adjustments. They found that integrated rehabilitation in patients with severe angina resulted in adding quality years to patient's lives. The program was also found to be cost effective. 17 There is clear evidence that patients with stable angina experience significant limitations resulting in a need to adjust their lifestyle. They reported indignation, a sense of caution, and a fear of the unknown. Patients report needing to make adjustments in their lifestyles because of these limitations. They want access to information sources and a better understanding of their disease in order to make adjustments in their lives. They expressed the need to have opportunities to discuss their disease with a specialist health care provider and felt that this was essential to their ability to manage their health. 18 Thus, antianginal medical therapies remain important despite optimal revascularization.
An education and support program for patients with chronic stable angina -A nursing initiative
Get Tough on Angina (GTOA) is a public health initiative designed to increase QOL in persons with chronic stable angina. In addition, GTOA aims to increase the public's awareness of chronic stable angina and its impact on health and QOL. GTOA was developed by the Preventive Cardiovascular Nurses Association. It includes three main components:
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• An educational brochure and handbook for patients and families available in English and Spanish; • A slide and script set for a four-part educational support group to be led by health care providers. Both slide and script sets include detailed information about the educational content, class activities, and homework.
• A slide and script set for a one hour community education forum about chronic stable angina.
The GTOA program is free of charge. All of the products can be ordered by emailing the Preventive C a r d i o v a s c u l a r N u r s e s A s s o c i a t i o n a t www.info@pcna.net.
The educational support group includes information about coronary artery disease, pathophysiology, medications and medical management, communication building, self-monitoring for symptoms, physical activity, nutrition, and medication compliance. The program emphasizes understanding and communication about feelings and emotions and provides a series of "LifeSkills" to reduce stress. 19 Communication with family, friends and health care providers is emphasized. Each session shares a similar format which includes: GTOA was piloted tested by nurses in 10 cities throughout the United States. Sixty-six patients participated in the ten pilot programs. Following the 4 weekly sessions, patients reported improved QOL scores as measured by the SAQ and were very satisfied with the program. Improved QOL remained at 8 weeks following the program. 21 "Get Tough on Angina" is ideally suited for use in cardiac rehabilitation programs and in clinics where patients with coronary artery disease are cared for.
Conclusion
Chronic stable angina is a common symptom that is rising in incidence along with an aging population and an improved ability to prevent death from coronary atherosclerotic vascular disease. In spite of advanced medical and interventional therapies, anginal symptoms remain common and negatively affect quality of life for millions. Angina also contributes enormously to personal, societal, and financial burdens attributed to poor health. Providing patients with a program designed to improve their understanding of angina with information about effective self care is critically important. Get Tough on Angina is an example of an education and support program designed to achieve improved Quality of Life for persons living with chronic stable angina. *The Get Tough on Angina program was made possible through an unrestricted educational grant from CV Therapeutics, Inc. to the Preventive Cardiovascular Nurses Association.
